Latest Competition News

NH3 Clean Energy has initiated the FEED phase for its WAH2 clean ammonia project, securing key partnerships and government support while raising $4 million to fuel development.

Quantum Graphite Limited has made significant strides in developing its Eyre Peninsula Graphite Hub, refining its Uley 2 Project financing structure, and updating its geological exploration model, signaling progress toward integrated downstream operations.

EcoGraf Limited advances key milestones in its vertically integrated battery anode materials business, including nearing completion of debt financing for the Epanko Graphite Project and securing a pivotal HFfree purification patent.

KGL Resources is making significant strides in preparing the Jervois Project for construction, leveraging higher copper, silver, and gold prices to optimise the project and secure funding. Exploration efforts and strategic partnerships are positioning the company for a 2026 construction start and 2027 production.

Clime Investment Management has bolstered its balance sheet with a $2.3 million placement and launched a strategic product review amid evolving market dynamics and industry consolidation.

McPherson’s Limited updates shareholders on its ongoing transformation journey, reporting modest core brand growth in FY25 and outlining a strategic outlook for FY26 focused on sustainable expansion and operational efficiency.

Jameson Resources has made significant strides in advancing its Crown Mountain Hard Coking Coal Project, progressing environmental assessments and Indigenous partnerships while securing fresh capital to support development.

Nexsen Limited has successfully completed an $8 million IPO and ASX listing, while advancing its kidney diagnostic tests and initiating clinical trials for its GBS Rapid Sensor targeting expedited FDA approval.

Korvest has reported a record $13.2 million profit for FY25, driven by strong performances in its EzyStrut and Galvanising divisions, and is now embarking on a major expansion of its Kilburn manufacturing site.

Imugene Limited reports an 81% overall response rate in its azer-cel CAR T-cell therapy trial for difficult lymphomas, alongside a $25 million capital raise that extends its cash runway to mid-2027.

EMVision Medical Devices has successfully closed an oversubscribed Share Purchase Plan, raising $2 million and bringing total recent capital to $14 million. This funding positions the company to advance pivotal clinical trials and regulatory milestones for its innovative neurodiagnostic devices.

FirstWave Cloud Technology reports a cash-flow positive quarter with a $2.85 million capital raise and advances its AI-powered compliance product, targeting a commercial release by November.